Legis Daily

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

USA119th CongressHRES-1079| House 
| Updated: 2/25/2026
Josh Gottheimer

Josh Gottheimer

Democratic Representative

New Jersey

Cosponsors (1)
Don Bacon (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This resolution acknowledges Charcot-Marie-Tooth disease (CMT) as a significant neurological disorder that impacts an estimated 126,000 individuals in the United States and millions worldwide. It highlights that CMT, an inherited condition damaging peripheral nerves, saw a decrease in federal research funding from 2021 to 2022 despite its widespread impact and the fact that its specific gene has not yet been identified. The House of Representatives expresses the critical need for robust funding for CMT research, specifically at the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH). The resolution further advocates for continued investment in research efforts to tackle CMT and other rare diseases for which there is currently no cure, underscoring the importance of dedicated resources to advance understanding and treatment options.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HRES 118-1039
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Feb 25, 2026
Submitted in House
Feb 25, 2026
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HRES 118-1039
    Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.


  • February 25, 2026
    Submitted in House


  • February 25, 2026
    Referred to the House Committee on Energy and Commerce.

Health

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

USA119th CongressHRES-1079| House 
| Updated: 2/25/2026
This resolution acknowledges Charcot-Marie-Tooth disease (CMT) as a significant neurological disorder that impacts an estimated 126,000 individuals in the United States and millions worldwide. It highlights that CMT, an inherited condition damaging peripheral nerves, saw a decrease in federal research funding from 2021 to 2022 despite its widespread impact and the fact that its specific gene has not yet been identified. The House of Representatives expresses the critical need for robust funding for CMT research, specifically at the National Institute of Neurological Disorders and Stroke (NINDS) within the National Institutes of Health (NIH). The resolution further advocates for continued investment in research efforts to tackle CMT and other rare diseases for which there is currently no cure, underscoring the importance of dedicated resources to advance understanding and treatment options.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HRES 118-1039
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Feb 25, 2026
Submitted in House
Feb 25, 2026
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HRES 118-1039
    Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.


  • February 25, 2026
    Submitted in House


  • February 25, 2026
    Referred to the House Committee on Energy and Commerce.
Josh Gottheimer

Josh Gottheimer

Democratic Representative

New Jersey

Cosponsors (1)
Don Bacon (Republican)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted